mRNA 2.0 Platform

Drug discovery and biotech · by Kernal Biologics

mRNA therapeutics platform that is intelligently programmed and selectively translated, using AI models to ensure selective translation in target cells and enabling scalable in vivo CAR-T therapies for cancer and autoimmune diseases.

What it does

mRNA therapeutics platform that is intelligently programmed and selectively translated, using AI models to ensure selective translation in target cells and enabling scalable in vivo CAR-T therapies for cancer and autoimmune diseases.

  • In vivo CAR-T therapies for cancer
  • In vivo CAR-T therapies for autoimmune diseases
Category
Drug discovery and biotech
Users
Patients with cancer, Patients with autoimmune diseases
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Kernal Biologics doesn't list prices publicly. Ask them for a quote.

Security and compliance

No security details published yet

Kernal Biologics hasn't published certifications or security practices for mRNA 2.0 Platform that we could find. Ask their team for audit reports.

Reviews

No reviews yet

Reviews come from people who use mRNA 2.0 Platform at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim mRNA 2.0 Platform